However, increased expression of HOXB9 showed better overall survival in colon adenocarcinoma, pancreatic ductal adenocarcinoma and gastric carcinoma patients15–17, indicating HOXB9 played an opposite role in these cancer progression. Here, HOXB9 is linked to pancreatic ductal adenocarcinoma.